The International AIDS Society Conference is not the loudest HIV meeting, nor the largest. But it is arguably the most important. It is where the raw data of hope and failure is examined under the brightest, most unforgiving lights.
The , organized by the International AIDS Society (IAS) , is the world's largest gathering on HIV and AIDS . It serves as a critical global platform where science, policy, and advocacy intersect to advance the HIV response . Upcoming Major Conferences
This is the world’s largest conference on any global health issue. It brings together roughly 15,000 to 20,000 participants—including scientists, policymakers, and people living with HIV—to bridge the gap between research and real-world implementation. international aids society conference
Every two years, the global HIV community converges. Not at the massive, sprawling World AIDS Conference, nor at the specialized scientific retreats, but at the . While less famous than its older sibling, the IAS Conference has carved out a unique and arguably more critical niche: it is the premier global forum where science meets strategy .
The IAS Conference was first held in 1986, and since then, it has become one of the largest and most influential gatherings on HIV/AIDS. The conference aims to: The International AIDS Society Conference is not the
The IAS Conference will continue to be a premier event in the global HIV/AIDS response. The next conference is scheduled to take place in 2023 in Brisbane, Australia.
Addressing the global funding crisis, protecting service infrastructure, and ensuring evidence-based policies drive the HIV response . IAS 2025 (13th IAS Conference on HIV Science) Date: July 13–17, 2025 . Location: Kigali, Rwanda, and Virtually . The , organized by the International AIDS Society
. It wasn’t just about making the medicine; it was about keeping people connected to care in a world where stigma and legal barriers—like the rising HIV criminalization reported in 2025—threatened to undo decades of progress. Voices from the Field Among the attendees was a peer researcher who had aged out of his adolescent program to become a navigator. To him, the conference wasn't just about the viral suppression rates or the debates over sterilizing vs. functional cures . It was about the "Road to Rio"—the initiative leading into
Unlike basic science meetings, IAS ensures every session has an “implementation” lens. A talk on reservoir persistence in HIV cure research is immediately followed by a discussion of clinical trial design in resource-limited settings. This forces basic scientists to think about feasibility—a rare and valuable constraint.